YOLFTbeta
Alaunos Therapeutics Inc

Alaunos Therapeutics Inc

TCRT · NASDAQ · Healthcare / Biotechnology

1.63USD+0.01 (+0.62%)

Price History

Full chart

Market Stats

Previous Close1.62
Open1.65
Day Range1.56 – 1.67
52-Week Range0.9692 – 4.59
Volume33.80K
Market Cap2.77M
P/E (TTM)0.00
Forward P/E18.48
EPS-1.75
Dividend Yield0.00%
Beta-0.97
50-Day Avg1.75
200-Day Avg2.57

About

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Holger Weis CPA
  • Employees1
  • Headquarters501 E. Las Olas Blvd., Fort Lauderdale, FL, United States, 33301, USA
  • Websitehttps://www.alaunos.com

Leadership

  • Mr. Holger Weis CPAChairman of the Board & CEO · b. 1963
  • Mr. Ferdinand GroenewaldVice President of Finance & Corporate Secretary · b. 1984

Financials

Income Statement

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.73K2.57K--------667.00K800.00K800.00K1.37M4.33M6.86M6.39M146.00K00398.00K2.92M5.00K10.00K5.00K
Growth (%)-+48.90%---------+19.94%0.00%+71.63%+215.51%+58.38%-6.88%-97.71%-100.00%--+634.17%-99.83%+100.00%-50.00%
Cost of Revenue------------------629.00K1.13M47.27M22.52M4.80M362.00K1.36M
Gross Profit1.73K2.57K--------667.00K800.00K800.00K1.37M4.33M6.86M6.39M146.00K-629.00K-1.13M-46.88M-19.60M-4.80M-352.00K-1.36M
Gross Margin100.00%100.00%--------100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%---11778.14%-670.64%-95960.00%-3520.00%-27160.00%
Operating Expense74.26K42.51K--------72.07M102.97M58.51M44.87M124.43M172.17M59.88M54.05M57.23M79.23M30.67M15.51M29.47M4.46M2.87M
Operating Income-72.53K-39.94K-35.84K-39.17K-9.79M-19.11M-28.57M-25.62M-12.12M-24.55M-71.40M-102.17M-57.71M-43.50M-120.10M-165.31M-53.49M-53.91M-57.86M-80.36M-77.55M-35.10M-34.27M-4.81M-4.22M
Operating Margin-4202.49%-1554.12%---------10704.65%-12771.13%-7214.13%-3168.17%-2772.39%-2409.37%-837.27%-36921.92%---19484.67%-1201.40%-685340.00%-48120.00%-84500.00%
EBITDA-71.78K-39.14K-35.36K-39.17K-9.42M-17.68M-26.17M-24.84M-7.32M-32.48M-71.40M-102.17M-56.98M-43.50M-119.74M-165.01M-53.12M-53.33M-117.17M-79.23M-74.97M-31.82M-30.90M-4.68M-4.17M
EBITDA Margin-4159.04%-1523.04%---------10704.65%-12771.13%-7121.88%-3168.17%-2764.15%-2405.00%-831.49%-36528.08%---18835.43%-1088.88%-618080.00%-46770.00%-83380.00%
Net Income-72.53K-39.94K-35.84K-39.17K-9.52M-17.86M-26.61M-25.23M-7.65M-32.67M-63.78M-96.13M-57.11M-31.78M-120.09M-165.30M-54.32M-53.12M-117.80M-78.85M-78.75M-37.73M-35.14M-4.68M-4.18M
Net Income Margin-4202.49%-1554.12%---------9561.92%-12016.50%-7138.38%-2314.71%-2772.11%-2409.23%-850.26%-36381.51%---19786.68%-1291.24%-702800.00%-46790.00%-83520.00%
R&D----5.59M10.39M18.99M17.25M4.56M12.91M57.08M83.45M42.85M32.71M106.78M157.79M45.08M34.13M38.33M52.70M49.64M25.02M16.28M362.00K1.36M
R&D as % of Total Revenue----------8558.17%10430.75%5356.50%2382.08%2465.03%2299.83%705.65%23379.45%--12473.12%856.19%325580.00%3620.00%27260.00%
Interest Expense--------4.47M8.12M7.62M6.04M606.00K11.72M12.00K10.00K830.00K789.00K120.69M385.00K1.19M3.15M1.92M0-
Interest Expense % of Total Revenue----------1142.73%754.63%75.75%853.46%0.28%0.15%12.99%540.41%--298.74%107.94%38420.00%0.00%-

Balance Sheet

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.88K50133219.49M29.51M36.73M12.57M49.74M61.52M108.11M83.40M71.75M45.24M153.72M106.35M105.61M95.05M109.11M146.34M94.86M64.94M8.26M2.75M2.97M
Total Liabilities5.50K17.84K25.72K21.05K2.29M2.98M6.36M5.83M21.63M30.97M36.50M34.96M22.37M11.40M66.35M183.65M202.41M9.49M14.10M22.36M36.81M26.38M1.96M692.00K813.00K
Total Equity-13.93K-17.33K-25.69K-21.02K7.20M26.53M30.37M6.74M28.10M30.55M71.61M48.45M49.38M33.84M87.37M-77.30M-96.81M85.56M95.01M123.98M58.06M38.55M6.31M2.06M2.15M
Cash4511533218.88M26.86M35.03M11.38M48.84M60.39M104.71M73.31M68.20M42.80M140.72M81.05M70.95M61.73M79.74M115.07M76.05M39.06M6.06M1.09M1.39M
Total Debt5.50K-----------------2.35M4.81M30.09M20.07M---
Net Debt5.05K-15-33-21-8.88M-26.86M-35.03M-11.38M-48.84M-60.39M-104.71M-73.31M-68.20M-42.80M-140.72M-81.05M-70.95M-61.73M-77.39M-110.25M-45.96M-18.99M-6.06M-1.09M-1.39M

Cash Flow

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-30.26K-11.77K-9.33K-7.31K-8.78M-14.42M-21.65M-23.52M-12.29M-19.69M-38.84M-78.83M-59.51M-36.65M-10.00K-58.33M-54.67M-49.46M-40.85M-57.01M-61.47M-29.23M-30.14M-4.97M-2.87M
Investing Cash Flow--316---130.20K-1.91M817.05K-131.00K-11.00K-186.00K-1.16M-1.56M-131.00K-193.00K-412.00K-551.00K-737.00K-459.00K-284.00K-9.78M-3.32M-193.00K1.35M--98.00K
Financing Cash Flow4.00K11.65K9.35K7.30K16.76M34.31M29.01M-49.77M31.43M84.31M48.98M54.54M11.44M98.34M-788.00K45.30M40.31M59.15M102.12M25.78M6.37M-18.14M03.26M
Capital Expenditure031600130.20K354.30K738.12K132.00K11.00K186.00K1.16M1.56M132.00K193.00K412.00K551.00K737.00K459.00K284.00K9.78M3.32M216.00K197.00K098.00K
Free Cash Flow-30.26K-12.09K-9.33K-7.31K-8.91M-14.78M-22.39M-23.65M-12.30M-19.88M-39.99M-80.39M-59.64M-36.84M-422.00K-58.88M-55.41M-49.92M-41.14M-66.79M-64.79M-29.45M-30.34M-4.97M-2.97M
Dividends Paid---------------7.12M-17.00M-------
FCF to OCF100.00%102.68%100.00%100.00%101.48%102.46%103.41%100.56%100.09%100.94%102.98%101.98%100.22%100.53%4220.00%100.94%101.35%100.93%100.70%117.15%105.41%100.74%100.65%100.00%103.42%
Dividend Paid to FCF----------------12.10%--34.05%-------

Earnings

Report DateSep 30, 2005Dec 31, 2005May 15, 2006Aug 14, 2006Nov 13, 2006Feb 13, 2007May 2, 2007Aug 13, 2007Nov 2, 2007Feb 21, 2008May 12, 2008Jul 31, 2008Oct 31, 2008Mar 24, 2009May 15, 2009Aug 14, 2009Nov 11, 2009Mar 18, 2010Apr 30, 2010Jul 30, 2010Nov 4, 2010Feb 3, 2011May 5, 2011Aug 1, 2011Nov 3, 2011Feb 29, 2012May 3, 2012Aug 2, 2012Nov 8, 2012Mar 18, 2013May 7, 2013Aug 8, 2013Oct 22, 2013Mar 3, 2014May 8, 2014Aug 7, 2014Oct 30, 2014Feb 26, 2015May 7, 2015Aug 10, 2015Nov 2, 2015Feb 24, 2016May 10, 2016Aug 9, 2016Nov 9, 2016Feb 16, 2017May 1, 2017Jul 31, 2017Nov 6, 2017Mar 1, 2018May 10, 2018Aug 8, 2018Nov 9, 2018Mar 5, 2019May 8, 2019Aug 8, 2019Nov 7, 2019Mar 2, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 25, 2021May 6, 2021Aug 13, 2021Nov 8, 2021Mar 30, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 7, 2023May 10, 2023Aug 14, 2023Nov 14, 2023Mar 5, 2024Apr 1, 2024Aug 14, 2024Nov 12, 2024Mar 31, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Aug 14, 2026Nov 13, 2026
EPS Estimate------54.00-37.50-42.00-51.00-59.00-58.50-54.00-39.00-31.50----0.12-15.00-18.75-21.00-34.12-12.00-34.00-42.00-0.26-33.00-34.50-42.00-0.29-41.10-37.12-30.00-0.14-13.50-25.50-16.12-0.14-19.00-48.61-18.94-0.07-12.00-15.90-16.60-0.11-14.22-18.43-20.29-0.14-19.06-18.52-16.73-0.11-12.30-12.24-13.50-0.08-12.75-13.75-13.49-0.10-15.81-17.57-18.86-0.08-9.90-10.25-10.75-0.07-6.60-6.75-5.25-0.45-4.50-----0.00--
EPS Actual-115.48-13571.83-66.42-64.78-33.95-57.00-43.50-46.50-52.50-69.00-61.50-46.50-39.00-31.50-23.51-16.89-19.82-0.14-16.50-18.00-27.00-17.55-25.50-19.20-31.25-0.19-37.50-45.00-34.50-0.37-42.00-30.13-16.78-0.09-14.70-16.69-17.83-0.09-15.00-16.50-21.00-0.07-13.50-15.00-16.50-0.11-22.50-19.50-19.50-0.13-22.50-18.00-19.50-0.08-12.00-13.50-64.50-0.09-13.50-13.50-15.00-0.11-15.00-16.50-16.50-0.05-7.50-7.50-6.00-0.04-6.00-6.00-4.41-0.49-17.09-0.71-0.70-0.46-0.67-0.63-0.55-0.41-
Surprise------5.56%-16.00%-10.71%-2.94%-16.95%-5.13%13.89%0.00%0.00%----16.67%-10.00%4.00%-28.57%48.56%-112.50%43.53%25.60%26.92%-13.64%-30.43%17.86%-27.59%-2.19%18.83%44.07%35.71%-8.89%34.55%-10.61%35.71%21.05%66.06%-10.88%0.00%-12.50%5.66%0.60%0.00%-58.23%-5.81%3.89%7.14%-18.05%2.81%-16.56%27.27%2.44%-10.29%-377.78%-12.50%-5.88%1.82%-11.19%-10.00%5.12%6.09%12.51%37.50%24.24%26.83%44.19%42.86%9.09%11.11%16.00%-8.89%-279.78%--------
Timing-----Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market----Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hours---

Key Statistics & Ratios

Market Cap2.77M
Enterprise Value2.87M
Trailing P/E0.00
Forward P/E18.48
PEG Ratio0.58
Price / Sales923.04
Price / Book4.60
EPS-1.75
Book Value0.262
Revenue (TTM)3.00K
Gross Profit (TTM)-1.64M
EBITDA-4.03M
Profit Margin0.00%
Operating Margin-135233.33%
Return on Equity-185.95%
Return on Assets-81.13%
Shares Outstanding2.54M
Shares Float1.98M
Beta-0.97
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 1 analystsTarget 1.75
  • Hold
    1

Ownership Breakdown

Institutions
4.23%
Insiders
13.28%
Retail / Other
82.49%

Top Institutional Holders

  • Geode Capital Management, LLC
    22.56K0.89%
  • BlackRock Inc
    21.35K0.84%
  • Vanguard Fiduciary Trust Co
    15.50K0.61%
  • Vanguard Capital Management, LLC
    14.06K0.55%
  • HRT FINANCIAL LLC
    13.33K0.52%
  • Citadel Advisors Llc
    11.87K0.47%
  • XTX Topco Ltd
    10.17K0.40%
  • UBS Group AG
    2.27K0.09%
  • Advisor Group Holdings, Inc.
    1.78K0.07%
  • Tower Research Capital LLC
    1.58K0.06%
  • SRS Capital Advisors Inc
    1.22K0.05%
  • Morgan Stanley - Brokerage Accounts
    6530.03%
  • Vanguard Global Advisers, LLC
    5010.02%
  • Wells Fargo & Co
    1900.01%
  • Royal Bank of Canada
    1850.01%

Top Fund Holders

  • Fidelity Extended Market Index
    12.17K0.52%
  • Fidelity Total Market Index
    2.38K0.10%
  • Fidelity Series Total Market Index
    2.32K0.10%
  • Fidelity Nasdaq Composite Index
    1.12K0.05%
  • Vanguard U.S. Eq Idx £ Acc
    5010.02%

Stock Splits

  • Jul 18, 20241:10
  • Feb 1, 20241:15